Cargando…
Interferon-gamma inhibits aldehyde dehydrogenase(bright) cancer stem cells in the 4T1 mouse model of breast cancer
BACKGROUND: Despite improvements in disease diagnosis, treatment, and prognosis, breast cancer is still a leading cause of cancer death for women. Compelling evidence suggests that targeting cancer stem cells (CSCs) have a crucial impact on overcoming the current shortcomings of chemotherapy and rad...
Autores principales: | Zhuang, Xiufen, Shi, Guilan, Hu, Xiao, Wang, Huiru, Sun, Wen, Wu, Yanhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769120/ https://www.ncbi.nlm.nih.gov/pubmed/34890380 http://dx.doi.org/10.1097/CM9.0000000000001558 |
Ejemplares similares
-
Ovarian Cancer Stem Cells Are Enriched in Side Population and Aldehyde Dehydrogenase Bright Overlapping Population
por: Yasuda, Kazuyo, et al.
Publicado: (2013) -
The Expression of Aldehyde Dehydrogenase Family in Breast Cancer
por: Qiu, Yan, et al.
Publicado: (2014) -
Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells
por: Shiraishi, Akira, et al.
Publicado: (2017) -
Aldehyde dehydrogenase 1A1 in stem cells and cancer
por: Tomita, Hiroyuki, et al.
Publicado: (2016) -
The Multifaceted Role of Aldehyde Dehydrogenases in Prostate Cancer Stem Cells
por: Püschel, Jakob, et al.
Publicado: (2021)